To explore the role of OIP5-AS1 in trastuzumab resistance, trastuzumab-resistant breast cancer cells, named SKBR3-TR and BT474-TR, were established using the parental SKBR3 and BT474 cells to continuously expose with increasing concentration of trastuzumab for more than 6 months. The gene discussed is OIP5; the disease is breast cancer.